Viatris to acquire Pacira BioSciences for $1.65 billion
Viatris Inc. (NASDAQ: VTRS) has agreed to acquire Pacira BioSciences, Inc. (NASDAQ: PCRX) for $36.50 per share in cash, representing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

